Symptoms of fatigue and depression in ischemic heart disease are driven by personality characteristics rather than disease stage: A comparison of CAD and CHF patients

European Journal of Preventive Cardiology

Volumn 15, Issue 5, 2008, Pages 583-588

  Smith, Otto R F ^a   Pedersen, Susanne S ^a,b   Van Domburg, Ron T ^b   Denollet, Johan ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

depressive symptoms; disease stage; fatigue; ischemic heart disease; type D personality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERSONALITY; PERSONALITY TEST; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; TYPE D PERSONALITY; UNSTABLE ANGINA PECTORIS; AGED; COMPARATIVE STUDY; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; TIME;

AGED; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE PROGRESSION; FATIGUE; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PERSONALITY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 58149393098     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283083e17     Document Type: Article

References (35)

1. Pedersen SS, Daemen J, Van De Sande M, Sonnenschein K, Serruys PW, Erdman RAM et al. Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents. J Psychosom Res 2007; 62: 447–453.
2. Brink E, Grankvist G. Associations between depression, fatigue, and life orientation in myocardial infarction patients. J Cardiovasc Nurs 2006; 21: 407–411.
3. Crane PB. Fatigue and physical activity in older women after myocardial infarction. Heart Lung 2005; 34: 30–38.
4. Drexler H, Coats AJS. Explaining fatigue in congestive heart failure. Annu Rev Med 1996; 47: 241–256.
5. Falk K, Swedberg K, Gaston-Johansson F, Ekman I. Fatigue and aneamia in patients with chronic heart failure. Eur J Heart Fail 2006; 8: 744–749.
6. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160: 1354–1360.
7. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.
8. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF et al. Relationship of depression to death or hospitalization in patients with heart failure. Arc Intern Med 2007; 167: 367–373.
9. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail 2005; 11: 288–292.
10. Appels A, Höppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 1987; 17: 15–24.
11. Pedersen SS, Middel B. Increased vital exhaustion among Type-D patients with ischemic heart disease. J Psychosom Res 2001; 51: 443–449.
12. Pedersen SS, Ong ATL, Serruys PW, Erdman RAM, Van Domburg RT. Type D personality and diabetes predict the onset of depressive symptoms in patients following percutaneous coronary intervention. Am Heart J 2006; 151: 367.e1–367.e6.
13. Pedersen SS, Denollet J, Van Gestel YR, Serruys PW, Van Domburg RT. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil 2008; 15: 203–209.
14. Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J. Type D personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 341–346.
15. Pedersen SS, Denollet J. Is Type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2006; 2: 205–213.
16. McGowan L, Dickens C, Percival D, Douglas J, Tomenson B, Creed F. The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res 2004; 57: 183–188.
17. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89–97.
18. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Nathan RE et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003; 145: 493–499.
19. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999–1005.
20. Lespérance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996; 58: 99–110.
21. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988; 9: 758–764.
22. Denollet J. Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). Psychol Med 1993; 23: 111–121.
23. Appels A, Kop W, Bar F, De Swart H, Mendes De Leon C. Vital exhaustion, extent of atherosclerosis, and the clinical course after successful percutaneous transluminal coronary angioplasty. Eur Heart J 1995; 16: 1880–1885.
24. Astin F, Jones K, Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty. Heart Lung 2005; 34: 393–401.
25. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB et al.; NORG Investigators. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362: 604–609.
26. Pick B, Molloy A, Hinds C, Pearce S, Salmon P. Post-operative fatigue following coronary artery bypass surgery: relationship to emotional state and to the catecholamine response to surgery. J Psychosom Res 1994; 38: 599–607.
27. Aboufakher R, Riba A, Jani SM, Goswami R, Schwartz S, Lins S et al.; The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Am Heart J 2005; 150: 455–458.
28. Gignac MA, Cott C, Badley EM. Adaptation to chronic illness and disability and its relationship to perceptions of independence and dependence. J Gerontol B Psychol Sci Soc Sci 2000; 55: 362–372.
29. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 2006; 15: 1533–1550.
30. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417–421.
31. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97: 167–173.
32. Pedersen SS, Lemos PA, Van Vooren PR, Liu TK, Daemen J, Erdman RA et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol 2004; 44: 997–1001.
33. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 2005; 131: 260–300.
34. Pedersen SS, Denollet J, Daemen J, Van De Sande M, De Jaegere PT, Serruys PW et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007; 62: 455–461.
35. Kubzansky LD, Cole SR, Kawachi I, Vokonas P, Sparrow D. Shared and unique contributions of anger, anxiety, and depression to coronary heart disease: a prospective study in the normative aging study. Ann Behav Med 2006; 31: 21–29.